Bank of America Upgrades Teleflex to Neutral

Analysts see potential upside of 12% for the medical technology company's stock.

Apr. 13, 2026 at 2:08pm

Got story updates? Submit your updates here. ›

An extreme close-up of complex, metallic medical machinery and equipment, conveying a sense of the precision and technological sophistication behind Teleflex's products.A close examination of the advanced medical technology that powers Teleflex's innovative product portfolio.Wayne Today

Bank of America has upgraded shares of Teleflex (NYSE:TFX) from an 'underperform' rating to a 'neutral' rating and set a $135.00 price target, indicating a potential upside of 12.04% from the stock's previous close.

Why it matters

This upgrade from Bank of America suggests a more positive outlook for Teleflex, a diversified medical technology company that specializes in critical care and surgical products. The upgrade could signal a shift in investor sentiment and potentially impact the stock's performance.

The details

In a research report, Bank of America cited the company's recent financial performance and market positioning as factors behind the upgrade. Teleflex has faced some challenges, with the company reporting a decline in revenue and earnings in its most recent quarter. However, the bank's analysts believe the stock is now reasonably valued and has the potential to see further upside.

  • Bank of America issued the upgrade on Monday, April 13, 2026.

The players

Teleflex

A diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals.

Bank of America

A multinational investment bank and financial services company headquartered in Charlotte, North Carolina. It is one of the largest banking institutions in the United States.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching Teleflex's future financial performance and market updates to see if the company can capitalize on the more positive outlook from Bank of America.

The takeaway

The upgrade from Bank of America suggests a potential turnaround for Teleflex, as the medical technology company navigates challenges in the industry and looks to regain investor confidence.